Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S005 11/25/02 12/9/02 11/26/02 Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S004 5/29/02 6/3/02 5/31/02 Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S003 4/30/02 5/2/02 5/1/02 Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S001 8/22/01 11/6/01 11/6/01 12/12/01 Visudyne (verteporfin) Injection, 15 mg, QLT Photo Therapeutics NDA 21-119 4/12/00 4/17/00 4/17/00 12/11/01 Visudyne Indications: for the treatment of age-related macular degeneration in patients with predominantly classic subfoveal choroidal neovascularization. Visudyne (verteporfin) Injection, QLT, Inc. | Visudyne (verteporfin for injection), QLT Inc., Labeling Revision

For the most up-to-date approval information, please locate this API using the drug index. For industry specific content, please visit USActives.com.